BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 27444232)

  • 1. Effects of Probabilities, Adverse Outcomes, and Status Quo on Perceived Riskiness of Medications: Testing Explanatory Hypotheses Concerning Gist, Worry, and Numeracy.
    Wilhelms EA; Fraenkel L; Reyna VF
    Appl Cogn Psychol; 2018; 32(6):714-726. PubMed ID: 30686857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why not? - Communicating stochastic information by use of unsorted frequency pictograms - a randomised controlled trial.
    Kasper J; Heesen C; Köpke S; Mühlhauser I; Lenz M
    Psychosoc Med; 2011; 8():Doc08. PubMed ID: 22053168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Genetic Breast Cancer Risk: Processing Loci of the
    Wolfe CR; Reyna VF; Widmer CL; Cedillos-Whynott EM; Brust-Renck PG; Weil AM; Hu X
    Learn Individ Differ; 2016 Jul; 49():178-189. PubMed ID: 28008216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Providing the Gist of Medical Expertise in the Context of Laws, Rules, and Guidelines: Fuzzy-Trace Theory's Alternative Approach to Improve Patient Communication.
    Edelson SM; Reyna VF
    J Law Med Ethics; 2023; 51(3):703-707. PubMed ID: 38088595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adapt/Exchange Decisions Depend on Structural and Surface Features: Effects of Solution Costs and Presentation Format.
    Müller R
    Behav Sci (Basel); 2024 Feb; 14(3):. PubMed ID: 38540494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study.
    Sherbini AA; Gwinnutt JM; Hyrich KL; ; Verstappen SMM
    Rheumatology (Oxford); 2022 Oct; 61(10):3930-3938. PubMed ID: 35078225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, piloting, and evaluation of an evidence-based informed consent form for total knee arthroplasty (EvAb-Pilot): a protocol for a mixed methods study.
    Weise A; Lühnen J; Bühn S; Steffen F; Zacher S; Lauberger J; Ates DM; Böhmer A; Rosenau H; Steckelberg A; Mathes T
    Pilot Feasibility Stud; 2021 May; 7(1):107. PubMed ID: 33985574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Unintended Consequences of Adverse Event Information on Medicines' Risks and Label Content.
    Furlan G; Power D
    Pharmaceut Med; 2020 Dec; 34(6):369-380. PubMed ID: 33196966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communicating Uncertainty in Written Consumer Health Information to the Public: Parallel-Group, Web-Based Randomized Controlled Trial.
    Büchter RB; Betsch C; Ehrlich M; Fechtelpeter D; Grouven U; Keller S; Meuer R; Rossmann C; Waltering A
    J Med Internet Res; 2020 Aug; 22(8):e15899. PubMed ID: 32773375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of factors associated with side-effect expectations from medical interventions.
    Smith LE; Webster RK; Rubin GJ
    Health Expect; 2020 Aug; 23(4):731-758. PubMed ID: 32282119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocebo effects of a simplified package leaflet compared to unstandardised oral information and a standard package leaflet: a pilot randomised controlled trial.
    Prediger B; Meyer E; Büchter R; Mathes T
    Trials; 2019 Jul; 20(1):458. PubMed ID: 31349865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communicating risk of medication side-effects: role of communication format on risk perception.
    Sawant R; Sansgiry S
    Pharm Pract (Granada); 2018; 16(2):1174. PubMed ID: 30023029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicating information concerning potential medication harms and benefits: What gist do numbers convey?
    Blalock SJ; Sage A; Bitonti M; Patel P; Dickinson R; Knapp P
    Patient Educ Couns; 2016 Dec; 99(12):1964-1970. PubMed ID: 27444232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presenting Numeric Information with Percentages and Descriptive Risk Labels: A Randomized Trial.
    Sinayev A; Peters E; Tusler M; Fraenkel L
    Med Decis Making; 2015 Nov; 35(8):937-47. PubMed ID: 25952743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numbers matter to informed patient choices: a randomized design across age and numeracy levels.
    Peters E; Hart PS; Tusler M; Fraenkel L
    Med Decis Making; 2014 May; 34(4):430-42. PubMed ID: 24246563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informing patients: the influence of numeracy, framing, and format of side effect information on risk perceptions.
    Peters E; Hart PS; Fraenkel L
    Med Decis Making; 2011; 31(3):432-6. PubMed ID: 21191122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising.
    West SL; Squiers LB; McCormack L; Southwell BG; Brouwer ES; Ashok M; Lux L; Boudewyns V; O'Donoghue A; Sullivan HW
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):447-58. PubMed ID: 23440924
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.